DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Eli Lilly - 2 Lilly - 2 Patrik Jonsson - 2 Lilly USA - 2 — - 1 Renee Rayburg - 1 Mercer - 1 Eli Lilly's - 1
Top related locs:
Mounjaro Government Minnesota Minneapolis Hennepin ZS U.S Carolina
Top related orgs:
Service - 1 Pharmaceutical - 1 Group - 1 Novo Nordisk's Wegovy - 1 Mayo Clinic - 1 University of Texas - 1 Hennepin Healthcare - 1 Medicare - 1

Search resuls for: "Lilly USA"


3 mentions found


☆ Getting hot new weight-loss drugs like Wegovy will still be a struggle in 2024
  + stars: | 2024-01-04 | by ( ) www.businessinsider.com   time to read: +11 min
AdvertisementIf you were hoping that powerhouse weight-loss drugs like Wegovy would be easier to get in 2024, you may be disappointed. Don't expect Medicare coverage any time soonMedicare could play a major role in expanding coverage of weight-loss drugs . Americans' hunger for weight-loss drugs, and the shockwaves it's likely to send through the culture and economy, are only just beginning. He oversees the state employee health plan, which saw costs skyrocket as thousands of workers suddenly started taking weight-loss drugs. People who are already getting weight-loss drugs will be able to keep taking them.
Persons: —, Renee Rayburg, Mercer, Eli Lilly's, Jose Luis Pelaez, there's, Wegovy, Bill Coyle, ZS, Eli Lilly, David Risinger, Lilly, Risinger, Morgan Stanley, Mounjaro, They're, That's, Patrik Jonsson, Lilly USA, Coyle, Dale Folwell, Folwell Organizations: Service, Pharmaceutical, Group, Novo Nordisk's Wegovy, Mayo Clinic, University of Texas, Hennepin Healthcare, Medicare, Capital Alpha Partners, Vanderbilt University, Nordisk's Wegovy, Novo Nordisk, pharma, Nordisk's, FDA, Pharma, UBS BioPharma Conference, Walmart, Jefferies, Nordisk Locations: Mounjaro, Government, Minnesota, Minneapolis, Hennepin, ZS, U.S, Carolina, North Carolina
☆ Eli Lilly appoints new obesity unit head ahead of key Mounjaro decision
  + stars: | 2023-10-04 | by ( Reuters Staff | ) www.reuters.com   time to read: +1 min
(Reuters) -Eli Lilly and Co on Wednesday appointed a new chief for its diabetes and obesity unit in a string of leadership changes ahead of a key regulatory decision on the use of its potential blockbuster drug Mounjaro as a weight-loss treatment. Slideshow ( 2 images )Mounjaro, chemically known as tirzepatide, is already being prescribed by doctors off-label as an obesity treatment. In his new role, Jonsson will oversee Lilly’s launched products and late-stage development of diabetes and obesity treatments, including tirzepatide and other candidates such as its next-generation obesity drug retatrutide and obesity pill orforglipron. Mason, who has also spent more than three decades with Lilly, oversaw the late-stage development and the launch of Mounjaro. The diabetes drug, which clocked in sales of $979.7 million in the latest quarter, belongs to a class of drugs known as GLP-1s that stimulate insulin production.
Persons: Eli Lilly, Patrik Jonsson, Lilly USA, Mike Mason, Jonsson, Lilly’s, Mason, Lilly, Daniel Skovronsky Organizations: Reuters Locations: Sweden, Scandinavia, Italy, Japan, Jonsson
☆ Eli Lilly sued for age discrimination by U.S. agency EEOC
  + stars: | 2022-09-26 | by ( Jonathan Stempel | ) www.reuters.com   time to read: +2 min
Register now for FREE unlimited access to Reuters.com RegisterFILE PHOTO: An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. REUTERS/Mike Segar/File PhotoSept 26 (Reuters) - Eli Lilly and Co was sued on Monday by the U.S. According to the EEOC, Fry suggested that the lack of millennials was a problem, and the Indianapolis-based company would target 40% "Early Career" hiring. The lawsuit filed in Indianapolis federal court accused Lilly of violating the federal Age Discrimination in Employment Act. The case is EEOC v Lilly USA LLC, U.S. District Court, Southern District of Indiana, No.
0 next >>
Total: 3